MarketScanners

MEIP Catalyst Trade With Technical Set-Up

Long
NASDAQ:MEIP   MEI Pharma, Inc
241 views
0
MEI Pharma , Inc. ( MEIP ), will be presenting data on Pracinostat, in combination with azacitidine in patients with advanced myelodysplastic syndrome ( MDS ) at a poster presentation at the American Society of Hematology Annual Meeting on December 10, 2012.

Stock looks good for at least a $.50 pop

Comments